Cidara Therapeutics Inc.

NASDAQ: CDTX · Real-Time Price · USD
63.88
0.33 (0.52%)
At close: Aug 15, 2025, 12:34 PM

Cidara Therapeutics Income Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Revenue
1.27M 63.91M 64.29M 49.57M
Cost of Revenue
84.88M 1.52M 143K 189K
Gross Profit
-83.61M 62.38M 64.14M 49.38M
Operating Income
-176.1M -24.48M -33.5M -42.26M
Interest Income
5.81M 2M 191K 212K
Pretax Income
-170.29M -22.49M -21.71M -42.47M
Net Income
-169.83M -22.93M -33.58M -42.47M
Selling & General & Admin
20.61M 18.33M 18.49M 18.74M
Research & Development
71.88M 68.53M 75.52M 73.09M
Other Expenses
n/a n/a n/a n/a
Operating Expenses
92.49M 86.86M 94.01M 91.83M
Interest Expense
n/a n/a n/a 212K
Selling & Marketing Expenses
n/a n/a n/a n/a
Cost & Expenses
177.38M 88.39M 94.01M 91.83M
Income Tax Expense
n/a 443K 272K 1.44M
Shares Outstanding (Basic)
6.35M 4.37M 3.49M 2.62M
Shares Outstanding (Diluted)
6.35M 4.37M 3.49M 2.62M
EPS (Basic)
-26.75 -5.25 -9.61 -16.2
EPS (Diluted)
-26.75 -5.25 -9.61 -16.19
EBITDA
-176.1M -24.36M -33.36M -42.26M
EBIT
-176.1M -24.48M -33.31M -42.26M
Depreciation & Amortization
233K 118K 143K 189K